Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$554M |
| 2 |
Apple
AAPL
|
+$513M |
| 3 |
Illumina
ILMN
|
+$360M |
| 4 |
argenx
ARGX
|
+$304M |
| 5 |
CTLT
CATALENT, INC.
CTLT
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$482M |
| 2 |
Sherwin-Williams
SHW
|
+$314M |
| 3 |
AbbVie
ABBV
|
+$310M |
| 4 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$244M |
| 5 |
Atlassian
TEAM
|
+$233M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.85% |
| 2 | Healthcare | 19.69% |
| 3 | Industrials | 10.47% |
| 4 | Financials | 10.02% |
| 5 | Consumer Discretionary | 9.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2451
American Well
AMWL
$221M
| $215K | ﹤0.01% |
4,590
+2,471
| +117% | +$158K |
|
|
INBX
2452
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $215K | ﹤0.01% |
+11,391
| New | +$265K |
|
|
SAVE
2453
DELISTED
Spirit Airlines, Inc.
SAVE
| $215K | ﹤0.01% |
+12,531
| New | +$234K |
|
|
PNT
2454
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $215K | ﹤0.01% |
29,554
+15,616
| +112% | +$116K |
|
2455
Thryv Holdings
THRY
$95.1M
| $214K | ﹤0.01% |
+9,295
| New | +$208K |
|
2456
Treace Medical Concepts
TMCI
$308M
| $214K | ﹤0.01% |
8,489
-534,791
| -98% | -$12.6M |
|
2457
Haverty Furniture Companies
HVT
$443M
| $214K | ﹤0.01% |
+6,707
| New | +$227K |
|
2458
V2X
VVX
$2.52B
| $214K | ﹤0.01% |
+5,382
| New | +$230K |
|
2459
AMC Global Media
AMCX
$486M
| $214K | ﹤0.01% |
+12,150
| New | +$227K |
|
|
MRUS
2460
DELISTED
Merus
MRUS
| $213K | ﹤0.01% |
+11,614
| New | +$202K |
|
2461
Independent Bank Corp
IBCP
$844M
| $213K | ﹤0.01% |
+11,989
| New | +$259K |
|
2462
British American Tobacco
BTI
$122B
| $213K | ﹤0.01% |
6,055
-1,453
| -19% | -$54.8K |
|
|
TPIC
2463
DELISTED
TPI Composites
TPIC
| $212K | ﹤0.01% |
+16,253
| New | +$207K |
|
|
GOOD
2464
Gladstone Commercial Corp
GOOD
$619M
| $212K | ﹤0.01% |
+16,790
| New | +$255K |
|
2465
Castle Biosciences
CSTL
$985M
| $211K | ﹤0.01% |
+9,296
| New | +$227K |
|
2466
Emergent Biosolutions
EBS
$228M
| $211K | ﹤0.01% |
20,348
-47,024
| -70% | -$568K |
|
2467
Hackett Group
HCKT
$285M
| $210K | ﹤0.01% |
+11,341
| New | +$229K |
|
2468
Interface
TILE
$2.24B
| $209K | ﹤0.01% |
25,798
+13,881
| +116% | +$137K |
|
2469
Xperi
XPER
$323M
| $209K | ﹤0.01% |
+19,154
| New | +$200K |
|
2470
ANI Pharmaceuticals
ANIP
$1.71B
| $209K | ﹤0.01% |
+5,262
| New | +$222K |
|
2471
Mercantile Bank Corp
MBWM
$1.05B
| $209K | ﹤0.01% |
+6,834
| New | +$229K |
|
2472
Perella Weinberg Partners
PWP
$1.31B
| $207K | ﹤0.01% |
22,848
+10,494
| +85% | +$105K |
|
2473
UiPath
PATH
$8.14B
| $207K | ﹤0.01% |
11,810
+65
| +0.6% | +$982 |
|
2474
Carriage Services
CSV
$534M
| $207K | ﹤0.01% |
+6,793
| New | +$216K |
|
|
SCPL
2475
DELISTED
SciPlay Corporation Class A Common Stock
SCPL
| $206K | ﹤0.01% |
+12,129
| New | +$199K |
|
Similar funds
Janus Henderson Group's Q1 2023 Portfolio in Review
As of Q1 2023, Janus Henderson Group held 2,845 positions worth $152B, up 8.3% from $140B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Janus Henderson Group's Q1 2023 filing shows 389 new, 1,670 increased, 578 reduced and 160 closed positions. Its largest new stake was GE HealthCare: 882,749 shares worth $72.4M. The largest sale was Meta Platforms (Facebook), an estimated $482M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 28% a quarter earlier, followed by Healthcare and Industrials.
- Janus Henderson Group's largest Q1 2023 buy was GE HealthCare: 882,749 shares worth $72.4M.
- Janus Henderson Group added most to Linde in Q1 2023, an estimated $554M increase.
- Janus Henderson Group's biggest Q1 2023 reduction was Meta Platforms (Facebook), cutting an estimated $482M.
- Janus Henderson Group fully exited Myovant Sciences Ltd. in Q1 2023, selling an estimated $31.7M.
- Janus Henderson Group's ten largest holdings make up 24% of its $152B portfolio in Q1 2023.
- Janus Henderson Group opened 389 new positions and closed 160 in Q1 2023.
- Janus Henderson Group's portfolio value rose 8.3% quarter-over-quarter to $152B.
Based on Janus Henderson Group's 13F filing for Q1 2023, filed 15 May 2023.